The Canadian Agency for Drugs and Technologies in Health (CADTH) issued a recommendation in 2020 regarding the use of esketamine (Spravato) for the treatment of major depressive disorder in adults.

Authors

• Person: Not available Organization: Frontiers in Psychiatry
  The Montreal model: an integrative biomedical-psychedelic ...

Sources

• The Montreal model: an integrative biomedical-psychedelic ... www.frontiersin.org Frontiers in Psychiatry via serper

Referenced by nodes (2)

• Major Depressive Disorder concept
• esketamine concept